Back to results
US 2001/0044540 A1Published application
Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors
OwnerRodney L. Parsons, Roberta L. Dorow +6inventors
InventorsRodney L. Parsons, Roberta L. Dorow, Akin H. Davulcu, Joseph M. Fortunak, Gregory D. Harris, Goss S. Kauffman, William A. Nugent, Lilian A. Radesca
Life of this patent
Estimating the term…
Abstract
This invention relates generally to the asymmetric synthesis of quinazolin-2-ones that are useful as inhibitors of HIV reverse transcriptase. The synthesis is accomplished through the chiral ligand mediated addition of cyclopropylacetylide.
Claims38
A process for making a compound of Formula Ia or Formula Ib:
- 21
- comprising:
- contacting a quinazolinone precursor of Formula IIa or IIb:
- 22
- with cyclopropylacetylene in the presence of a chiral moderator and a base, wherein the chiral moderator is a compound selected from:
- 23
3 more elements
A process for making a compound of Formula Ia or Formula Ib:
- 28
- comprising:
- contacting a quinazolinone precursor of Formula IIa or IIb:
- 29
- with cyclopropylacetylene in the presence of a chiral moderator and a base, wherein the chiral moderator is a compound that provides an enantiomeric excess of at least 30 to 100%.
2 more elements
Dependencies are inferred from the claim text.